Latest Breaking News On - Tai slyne - Page 1 : comparemela.com

Health your username 15 hours ago Athira Pharma, Inc. and its CEO, Leen Kawas, were sued by two groups of stockholder plaintiffs Friday. The first suit, by plaintiffs Fan Wang and Hang Gao, was brought over claims that the company violated federal securities laws and defrauded its investors through misleading statements about the status of the company.  The plaintiffs have requested class certification for all investors who held stock in Athira between September 2020 and June 17, 2021. The plaintiffs are demanding a trial by jury, and ultimately seeking punitive and compensatory damages, litigation costs, as well as any other relief the court may deem just and proper. The case was filed Friday in the Western District of Washington.

United statesWashington state universityTai slyneAthira pharma incKeller rohrbackSecurities exchangeAthira pharmaLeen kawasFan wangChang gaoWestern districtSecurities exchange actTousley brainஒன்றுபட்டது மாநிலங்களில்வாஷிங்டன் நிலை பல்கலைக்கழகம்அதிரா பார்மா இன்க்